Examkin

Question

Difficulty: Very hardPulmonary and Critical Care

A 68-year-old man is evaluated in the intensive care unit on day 3 of mechanical ventilation for severe community-acquired pneumonia. He has a history of severe chronic obstructive pulmonary disease (COPD) and heart failure with preserved ejection fraction. He was intubated on admission due to hypercapnic respiratory failure.

His ventilator settings are:
Mode: Volume assist-control
Tidal volume: 450 mL (6 mL/kg ideal body weight)
Respiratory rate: 14/min
PEEP: 5 cm H2OH_2O
FiO2FiO_2: 0.40

Today, the ventilator alarms for high airway pressures. Vital signs are temperature 37.1 °C (98.8 °F), pulse 112/min, and blood pressure 135/85 mmHg.

Ventilator parameters show:
Peak airway pressure: 58 cm H2OH_2O (was 32 cm H2OH_2O yesterday)
Plateau airway pressure: 24 cm H2OH_2O (was 23 cm H2OH_2O yesterday)

Physical examination reveals jugular venous distension 9 cm above the sternal angle. Breath sounds are diminished bilaterally with a notably prolonged expiratory phase. No crackles are heard.

Current arterial blood gas on the above settings:
pH: 7.27
PaCO2PaCO_2: 66 mmHg
PaO2PaO_2: 70 mmHg
HCO3−HCO_3^-: 30 mEq/L
(A baseline blood gas from 3 months ago showed: pH 7.36, PaCO2PaCO_2 56 mmHg, HCO3−HCO_3^- 31 mEq/L)

Blood cultures drawn on admission are now finalizing and grow only *Streptococcus pneumoniae*, which is pan-sensitive, including to ceftriaxone. The patient is currently receiving intravenous vancomycin, piperacillin-tazobactam, and azithromycin.

Which of the following are the most appropriate next steps in management? (Select all that apply)

  1. Administer in-line albuterol and ipratropiumAnswer
  2. Discontinue current antibiotics and initiate intravenous ceftriaxoneAnswer
  3. C
    Administer intravenous furosemide
  4. D
    Administer intravenous sodium bicarbonate
  5. E
    Continue the current broad-spectrum antibiotic regimen
  6. F
    Increase the ventilator respiratory rate to 22/min

Answer

The most appropriate next steps are to administer in-line albuterol and ipratropium, and to discontinue the current antibiotics to initiate intravenous ceftriaxone.
The correct interventions address the two acute management issues for this patient: acute bronchospasm and antibiotic de-escalation. First, the isolated elevation in peak inspiratory pressure (PIP = 58 cm H2OH_2O) with a normal plateau pressure (Pplat = 24 cm H2OH_2O) creates a wide PIP-Pplat gradient, pathognomonic for increased airway resistance. Combined with the prolonged expiratory phase, this indicates a severe acute COPD exacerbation (bronchospasm), which should be treated immediately with in-line albuterol and ipratropium. Second, the finalized blood cultures demonstrate a pan-sensitive *Streptococcus pneumoniae*. Adhering to the principles of antibiotic stewardship, the empiric broad-spectrum coverage (vancomycin and piperacillin-tazobactam) must be discontinued and replaced with targeted therapy (ceftriaxone).

Step-by-Step Solution

1
Evaluate the ventilator pressures.
Peak airway pressure is significantly elevated (58 cm H2OH_2O) while plateau pressure remains normal (24 cm H2OH_2O).
An increased PIP-to-Pplat gradient (>5-10 cm H2OH_2O) isolates the problem to increased airway resistance rather than decreased lung compliance.
2
Correlate with physical examination.
The patient has a prolonged expiratory phase and no crackles.
This confirms that the increased airway resistance is due to acute bronchospasm (COPD exacerbation), which must be treated with bronchodilators.
3
Analyze the acid-base status.
The ABG shows an acute-on-chronic respiratory acidosis (pH 7.27, PaCO2PaCO_2 66 mmHg).
The primary issue is acute hypoventilation due to bronchospasm. Bicarbonate is not indicated for respiratory acidosis, and increasing the respiratory rate would paradoxically worsen air trapping in COPD.
4
Review culture data for antibiotic management.
Blood cultures grow a pan-sensitive *Streptococcus pneumoniae*.
Antibiotic stewardship requires de-escalation from empiric broad-spectrum therapy to a targeted, narrow-spectrum agent like ceftriaxone once sensitivities are known.

Key Concept

Elevated peak inspiratory pressure with a normal plateau pressure indicates increased airway resistance (e.g., bronchospasm, mucous plugging, tube kinking), not decreased lung compliance (e.g., pulmonary edema, ARDS, pneumothorax). Concurrently, finalized culture data mandates de-escalation of empiric broad-spectrum antibiotics to targeted therapy.
Rate this question

Topics

Pulmonary and Critical Care

More questions from this topic